HDI Global Insurance Company, US subsidiary of HDI Global, has launched its excess life sciences liability policy, offering coverages up to US$10 million in capacity.
Brian Carlsen, who recently joined HDI as an assistant vice president, will serve as its new US life sciences lead. He will be responsible for building out the company’s book of business within the region.
Carlsen brings 16 years of underwriting experience, with the last 10 being focused exclusively on life sciences placements. Prior to joining HDI, he was life sciences underwriting manager for the East Territory at Markel.
The new offering targets biotechnology and specialty pharmaceutical manufacturers and distributors, implantable medical device manufacturers, blood plasma manufacturers, and contract manufacturing and contract development manufacturing organisations.
Marco Hensel, chief underwriting officer at HDI Global Insurance Company, says: “HDI is committed to providing our insureds with bespoke solutions within the life sciences segment.
“The launch of our US life sciences division is another example of HDI’s continued focus on growth within the region and to act as a true partner in transformation for our clients in times of exceptional acceleration within the medical realm.”
Dani Maurer, head of Liability Global Risk at HDI, adds: “[Carlsen] brings extensive experience with small to large life sciences firms, underwriting accounts ranging from start-ups to large multinational corporations. His expertise will play a key role in HDI’s product line expansion within the US.”
